
The Pill for Him
A contraceptive pill for men has been promised for decades. Dr Alex Lathbridge explores some of the methods in development and why it's taking so long to get them to market.
For decades, the burden of contraception has fallen disproportionately on women, navigating the physical, emotional and social consequences of preventing pregnancy. But what would happen if men had a contraceptive options of their own? And why, despite decades of research, has a reliable male contraceptive yet to reach the market?
In The Pill for Him, Dr Alex Lathbridge asks why more contraception options for men are needed and whether there is an appetite for them. He looks back on past failures and explores whether current developmental drugs could transform the way we think about fertility, relationships and reproductive rights.
Focusing on the development of YCT-529, an experimental, non-hormonal male contraceptive that blocks the action of retinoic acid, stopping sperm production in its tracks, Alex finds out why developing a new contraceptive for men is so difficult - both biologically and against the backdrop of a risk averse pharmaceutical industry.
An exploration of science, gender and the business of medicine, The Pill for Him investigates whether the future of contraception could finally become a shared endeavour.
On radio
Broadcasts
- Mon 28 Dec 202620:32GMTBBC World Service Americas and the Caribbean, UK DAB/Freeview, Online & Europe and the Middle East only
- Mon 28 Dec 202621:32GMTBBC World Service except Online, Americas and the Caribbean, Europe and the Middle East & UK DAB/Freeview
- Tue 29 Dec 202605:32GMTBBC World Service Australasia, Americas and the Caribbean, South Asia & East Asia only
- Tue 29 Dec 202613:32GMTBBC World Service Australasia, East and Southern Africa, News Internet & West and Central Africa only
The Curious Cases of Rutherford and Fry
Podcast
![]()
Discovery
Explorations in the world of science.


